Nuveen Asset Management, LLC Alpine Immune Sciences, Inc. Transaction History

Nuveen Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.75 - $41.6 $6.8 Million - $15.9 Million	383,209 Added 294.85%	513,175 $20.3 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $312,401 - $739,667	36,581 Added 39.17%	129,966 $2.48 Million
Q3 2023 Nov 14, 2023	SELL	$10.13 - $13.98 $2,957 - $4,082	-292 Reduced 0.31%	93,385 $1.07 Million
Q2 2023 Aug 14, 2023	BUY	$6.84 - $11.91 $423,724 - $737,800	61,948 Added 195.24%	93,677 $962,000
Q4 2022 Feb 14, 2023	BUY	$5.45 - $7.35 $16,606 - $22,395	3,047 Added 10.62%	31,729 $233,000
Q3 2022 Nov 14, 2022	BUY	$6.89 - $9.39 $70,526 - $96,116	10,236 Added 55.49%	28,682 $207,000
Q2 2021 Aug 16, 2021	BUY	$8.81 - $15.03 $162,509 - $277,243	18,446 New	18,446 $166,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.